Complementary Healthcare Analysis - 2019-09-11
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
Long/Short Equity, Healthcare, Biotech
Contributor Since 2017
Avisol Capital Partners runs the Total Pharma Tracker Seeking Alpha Marketplace service. This is managed by Dr Asok Dutta, BVScAH and Dr Udaya Kumar Maiya, MD Oncologist. The service offers end-to-end research on both investing and trading ideas everyday, and includes a 150-stock watchlist and two 40-stock model portfolios that are continuously tracked.
Dr Dutta is a retired veterinary surgeon. He has over 40 years experience in the industry. Dr Maiya is a well-known oncologist who has 30 years in the medical field, including as Medical Director of various healthcare institutions. Both doctors are also avid private investors. They are assisted by a number of finance professionals in developing this service.
If you want to check out our service, go here - https://seekingalpha.com/author/avisol-capital-partners/research
Disclaimer - we are not investment advisors.
Dr Dutta is a retired veterinary surgeon. He has over 40 years experience in the industry. Dr Maiya is a well-known oncologist who has 30 years in the medical field, including as Medical Director of various healthcare institutions. Both doctors are also avid private investors. They are assisted by a number of finance professionals in developing this service.
If you want to check out our service, go here - https://seekingalpha.com/author/avisol-capital-partners/research
Disclaimer - we are not investment advisors.
| Top Gainers | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Mallinckrodt plc (MNK) | 325.14M | 3.88 | 84.76% | 53,332,812 | |
| Teva Pharmaceutical Industries Limited (TEVA) | 8.60B | 8.13 | 9.27% | 45,184,072 | |
| Endo International plc (ENDP) | 613.24M | 4.00 | 30.29% | 24,347,826 | |
| Immunomedics, Inc. (IMMU) | 3.07B | 15.59 | 17.39% | 6,540,035 | |
| Clovis Oncology, Inc. (CLVS) | 324.84M | 6.00 | 13.42% | 4,749,332 | |
| Top Losers | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Merit Medical Systems, Inc. (MMSI) | 1.50B | 27.98 | -9.54% | 3,588,370 | |
| Adverum Biotechnologies, Inc. (ADVM) | 742.11M | 11.59 | -6.91% | 1,830,814 | |
| Option Care Health, Inc. (BIOS) | 2.27B | 3.22 | -6.40% | 1,352,553 | |
| Zymeworks Inc. (ZYME) | 1.03B | 26.98 | -6.58% | 511,032 | |
| Nuvectra Corporation (NVTR) | 31.79M | 1.77 | -5.35% | 482,719 | |
| High volume stocks reaching new highs | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Catalyst Pharmaceuticals, Inc. (CPRX) | 674.49M | 6.92 | 4.37% | 2,763,090 | |
| Ardelyx, Inc. (ARDX) | 390.18M | 6.04 | 7.47% | 2,638,146 | |
| High volume stocks reaching new lows | |||||
| Company | Market Cap | Price | Change% | Volume | |
| BioMarin Pharmaceutical Inc. (BMRN) | 13.38B | 73.59 | 2.31% | 1,203,661 | |
| Regeneron Pharmaceuticals, Inc. (REGN) | 30.36B | 283.72 | 1.69% | 1,159,889 | |
| Zafgen, Inc. (ZFGN) | 24.84M | 0.66 | 0.47% | 1,026,276 | |
| Ligand Pharmaceuticals Incorporated (LGND) | 1.75B | 90.19 | 4.57% | 617,796 | |
| Obalon Therapeutics, Inc. (OBLN) | 9.88M | 1.73 | 0.58% | 523,457 | |
| Major Analyst Upgrades | |||||
| Company | Current Rating | New Rating | Analyst | Current Price | Target Price |
| AVEO Pharmaceuticals (AVEO) | Neutral | Buy | HC Wainwright | $0.92 | $1.75 |
| Bicycle Therapeutics (BCYC) | Neutral | Buy | Goldman Sachs Group | $7.03 | |
| Lexicon Pharmaceuticals (LXRX) | Hold | Buy | Gabelli | $1.72 | $3.00 |
| Major Analyst Downgrades | |||||
| Company | Current Rating | New Rating | Analyst | Current Price | Target Price |
| Consort Medical (CSRT) | Hold | Shore Capital | GBX 742 | ||
| Davita (DVA) | Outperform | Market Perform | William Blair | $61.66 | |
| Neurotrope (NTRP) | Buy | Neutral | Janney Montgomery Scott | $0.92 | |
| Major Insider Buys | |||||
| Company | Insider Name | Insider Title | Price | Qty | Value |
| Aldeyra Therapeutics, Inc. (ALDX) | Clark David J | Chief Medical Officer | $5.06 | 5000 | +$25,311 |
| Catalent, Inc. (CTLT) | Lucier Gregory T | Dir | $51.64 | 2000 | +$103,280 |
| Mirum Pharmaceuticals, Inc. (MIRM) | Clements Ian | SVP Finance, Communications | $11.51 | 4000 | +$46,039 |
| Fischer Laurent | Dir | $10.60 | 4650 | +$49,303 | |
| Peetz Christopher | Pres, CEO | $11.02 | 9070 | +$99,938 | |
| Vig Pamela | Chief Scientific Officer | $10.97 | 1612 | +$17,682 | |
| Organogenesis Holdings Inc. (ORGO) | Avista Capital Managing Member Iv, LLC | Dir, 10% | $5.18 | 537000 | +$2,782,529 |
| Nussdorf Glenn H | Dir, 10% | $5.03 | 10000 | +$50,274 | |
| Major Insider Sells | |||||
| Company | Insider Name | Insider Title | Price | Qty | Value |
| Arena Pharmaceuticals Inc (ARNA) | Aurentz Vincent | EVP, CBO | $50.72 | -65000 | -$3,296,700 |
| Spector Steven W | EVP, GC, Sec | $50.59 | -44084 | -$2,230,388 | |
| Biospecifics Technologies Corp (BSTC) | Wegman Toby | Dir, 10% | $55.17 | -10000 | -$551,677 |
| Emergent Biosolutions Inc. (EBS) | Zoon Kathryn C | Dir | $56.12 | -1509 | -$84,692 |
| Fibrogen Inc (FGEN) | Kurkijarvi Kalevi | Dir | $40.95 | -6000 | -$245,723 |
| Pfenex Inc. (PFNX) | Lucy Patrick K. | Chief Business Officer | $8.00 | -6000 | -$48,021 |
| Reata Pharmaceuticals Inc (RETA) | Castellanos Elaine | Principal Accounting Officer | $85.00 | -2000 | -$170,000 |
| Teva Pharmaceutical Industries Ltd (TEVA) | Daniell Richard | EVP, European Commercial | $7.16 | -333 | -$2,384 |
Index Watch
NASDAQ Health CareINDEXNASDAQ: IXHC
iShares NASDAQ Biotechnology Index
NASDAQ: IBB